Literature DB >> 9801888

Complications of surgery for epiretinal membranes.

G Donati1, A D Kapetanios, C J Pournaras.   

Abstract

PURPOSE: Surgery has been successful in removing epiretinal membranes (ERM) from the macula, allowing some improvement in vision in 80-90% of patients; however, complications are relatively frequent. We conducted a retrospective study to evaluate the rate of peri- and postoperative complications and their influence on functional outcome of eyes having been operated on for ERM.
MATERIAL AND METHODS: Preoperative findings, intraoperative and postoperative complications as final results of 70 consecutive cases of idiopathic or secondary ERM operated on by the same retina surgeon were analyzed.
RESULTS: In all cases the ERMs were successfully removed from the fovea. The mean visual acuity (VA) increased from 0.34 +/- 0.2 to 0.54 +/- 0.31 (P < 0.05) postoperatively. Idiopathic and secondary ERM both showed significant improvement after surgery. Complications included intraoperative hemorrhage and retinal tears and postoperative progressive nuclear sclerosis, retinal tears causing detachments, macular edema and retinal pigmentary epitheliopathy. Final VA was not significantly different from the mean after complications, apart from when retinal detachments involved the macular area.
CONCLUSIONS: Performing surgery for ERM is worthwhile in eyes with major decreased VA and in eyes with metamorphopsia but only moderately reduced vision. Postoperative complications are frequent but can usually be managed successfully. Of them, only retinal detachment has a negative effect on the final functional outcome.

Entities:  

Mesh:

Year:  1998        PMID: 9801888     DOI: 10.1007/s004170050152

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN: 0721-832X            Impact factor:   3.117


  18 in total

1.  Outcomes of idiopathic macular epiretinal membrane removal with and without internal limiting membrane peeling: a comparative study.

Authors:  Ji Woong Lee; In Taek Kim
Journal:  Jpn J Ophthalmol       Date:  2010-04-18       Impact factor: 2.447

2.  Quantification of metamorphopsia in patients with epiretinal membranes before and after surgery.

Authors:  Carl Arndt; Olivier Rebollo; Sylvie Séguinet; Philippe Debruyne; Georges Caputo
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2007-08       Impact factor: 3.117

3.  Improvement of horizontal macular contraction after surgical removal of epiretinal membranes.

Authors:  H K Yang; S J Kim; Y S Jung; K G Kim; J H Kim; H G Yu
Journal:  Eye (Lond)       Date:  2011-04-01       Impact factor: 3.775

4.  Surgical results of idiopathic and secondary epiretinal membrane.

Authors:  Kyung Tae Kang; Kwang Soo Kim; Yu Cheol Kim
Journal:  Int Ophthalmol       Date:  2014-10-21       Impact factor: 2.031

5.  [Vitreoretinal secondary procedures following elective macular surgery].

Authors:  A Hager; S Ehrich; W Wiegand
Journal:  Ophthalmologe       Date:  2004-01       Impact factor: 1.059

6.  Anatomic and functional results of idiopathic macular epiretinal membrane surgery.

Authors:  Mehmet Ozgur Cubuk; Erkan Unsal
Journal:  Int J Ophthalmol       Date:  2020-04-18       Impact factor: 1.779

7.  Delayed onset inner nuclear layer cystic changes following internal limiting membrane removal for epimacular membrane.

Authors:  Eric J Sigler; John C Randolph; Steve Charles
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2013-01-10       Impact factor: 3.117

8.  Surgery for idiopathic epiretinal membrane.

Authors:  Ammar M Yusuf; Mukhtar Bizrah; Catey Bunce; James W Bainbridge
Journal:  Cochrane Database Syst Rev       Date:  2021-03-24

9.  The clinical course of the idiopathic epiretinal membrane after surgery.

Authors:  Soon Il Kwon; Sung Ju Ko; In-Won Park
Journal:  Korean J Ophthalmol       Date:  2009-12-04

10.  Comparison of efficacy and safety between transconjunctival 23-gauge and conventional 20-gauge vitrectomy systems in macular surgery.

Authors:  Tugba Goncu; Gokhan Gurelik; Berati Hasanreisoglu
Journal:  Korean J Ophthalmol       Date:  2012-09-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.